Vantive

Vantive is an independent company that emerged from Baxter in 2025, building on a 70-year legacy in kidney care and vital organ support therapies. The company is dedicated to advancing treatments for acute and chronic kidney diseases, aiming to enhance patient outcomes and extend lives through innovative medical technologies and digital solutions. Vantive offers a comprehensive range of therapies, including advanced dialysis systems for kidney failure, digital connectivity tools for therapy management, and clinical services that support healthcare providers. The company serves over one million patients annually in more than 70 countries, collaborating closely with healthcare providers, clinicians, and care teams to deliver tailored solutions for kidney and organ care. With a mission of "Extending Lives, Expanding Possibilities," Vantive focuses on addressing the challenges in kidney and organ care through its integrated approach, which combines innovative therapies and advanced services.